These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29803790)

  • 1. Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1.
    Li SZ; Zeng F; Li J; Shu QP; Zhang HH; Xu J; Ren JW; Zhang XD; Song XM; Du RL
    Cancer Lett; 2018 Sep; 431():43-53. PubMed ID: 29803790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
    Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
    World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
    Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
    J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLK-mediated phosphorylation of HDAC1 negatively regulates Wnt signaling.
    Masoumi KC; Daams R; Sime W; Siino V; Ke H; Levander F; Massoumi R
    Mol Biol Cell; 2017 Jan; 28(2):346-355. PubMed ID: 27903773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus-based RNA silencing of Nemo-like kinase (NLK) inhibits the CAL 27 human adenosquamos carcinoma cells proliferation and blocks G0/G1 phase to S phase.
    Zhang B; Li KY; Chen HY; Pan SD; Chen SF; Zhang WF; Xia CP; Jiang LC; Liu XB; Zhao FJ; Yuan DY; Wang le X; Wu YP; Liu SW
    Int J Med Sci; 2013; 10(10):1301-6. PubMed ID: 23983589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
    Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
    J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
    Han Y; Kuang Y; Xue X; Guo X; Li P; Wang X; Guo X; Yuan B; Zhi Q; Zhao H
    Biomed Pharmacother; 2014 Jun; 68(5):497-505. PubMed ID: 24972723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer.
    Wang J; Yang ZH; Chen H; Li HH; Chen LY; Zhu Z; Zou Y; Ding CC; Yang J; He ZW
    BMC Cancer; 2016 Mar; 16():257. PubMed ID: 27036119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis.
    Lv M; Li Y; Tian X; Dai S; Sun J; Jin G; Jiang S
    Drug Des Devel Ther; 2016; 10():3737-3746. PubMed ID: 27895463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of ATF5 by TAK1-Nemo-like kinase critically regulates the interleukin-1β-stimulated C/EBP signaling pathway.
    Zhang ZY; Li SZ; Zhang HH; Wu QR; Gong J; Liang T; Gao L; Xing NN; Liu WB; Du RL; Zhang XD
    Mol Cell Biol; 2015 Mar; 35(5):778-88. PubMed ID: 25512613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells.
    Wu M; Seto E; Zhang J
    Oncotarget; 2015 May; 6(13):11252-63. PubMed ID: 25816777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Nemo-like Kinase in T Cells Reduces Single-Positive CD8
    Daams R; Sime W; Leandersson K; Sitnicka E; Massoumi R
    J Immunol; 2020 Oct; 205(7):1830-1841. PubMed ID: 32839237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Methylcholanthrene, an AhR agonist, caused cell-cycle arrest by histone deacetylation through a RhoA-dependent recruitment of HDAC1 and pRb2 to E2F1 complex.
    Chang CC; Sue YM; Yang NJ; Lee YH; Juan SH
    PLoS One; 2014; 9(3):e92793. PubMed ID: 24658119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction among Rb/p16, Rb/E2F1 and HDAC1 proteins in gallbladder carcinoma.
    Wang X; Huang K; Xu L
    J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):729-31. PubMed ID: 20037816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer.
    Malaney P; Palumbo E; Semidey-Hurtado J; Hardee J; Stanford K; Kathiriya JJ; Patel D; Tian Z; Allen-Gipson D; Davé V
    Cell Cycle; 2018; 17(8):947-962. PubMed ID: 29108454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the E2F1/Rb/HDAC1 axis with the small molecule HR488B effectively inhibits colorectal cancer growth.
    Duan N; Hu X; Qiu H; Zhou R; Li Y; Lu W; Zhu Y; Shen S; Wu W; Yang F; Liu N
    Cell Death Dis; 2023 Dec; 14(12):801. PubMed ID: 38062013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
    Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.
    Huang Y; Yang Y; He Y; Li J
    Tumour Biol; 2015 Dec; 36(12):9147-52. PubMed ID: 26427665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nemo-like kinase increases taxol sensitivity in laryngeal cancer.
    Dong JR; Guo N; Zhao JP; Liu PD; Feng HH; Li Y
    Asian Pac J Cancer Prev; 2013; 14(12):7137-41. PubMed ID: 24460265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RORα binds to E2F1 to inhibit cell proliferation and regulate mammary gland branching morphogenesis.
    Xiong G; Xu R
    Mol Cell Biol; 2014 Aug; 34(16):3066-75. PubMed ID: 24891616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.